Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-340364
Filing Date
2026-08-07
Accepted
2026-08-07 16:30:52
Documents
104
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q btmd-20260630.htm   iXBRL 10-Q 3254738
2 EX-10.1 btmd-ex10_1.htm EX-10.1 146914
3 EX-10.2 btmd-ex10_2.htm EX-10.2 159744
4 EX-10.3 btmd-ex10_3.htm EX-10.3 82160
5 EX-10.4 btmd-ex10_4.htm EX-10.4 35460
6 EX-31.1 btmd-ex31_1.htm EX-31.1 17805
7 EX-31.2 btmd-ex31_2.htm EX-31.2 17917
8 EX-32.1 btmd-ex32_1.htm EX-32.1 10752
9 EX-32.2 btmd-ex32_2.htm EX-32.2 10748
10 GRAPHIC img102560828_0.gif GRAPHIC 2185
  Complete submission text file 0001193125-26-340364.txt   14069381

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT btmd-20260630.xsd EX-101.SCH 1566871
108 EXTRACTED XBRL INSTANCE DOCUMENT btmd-20260630_htm.xml XML 2830869
Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Filer) CIK: 0001819253 (see all company filings)

EIN.: 851791125 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40128 | Film No.: 261254777
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)